These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30366617)

  • 61. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein arginine methyltransferase 5: a potential cancer therapeutic target.
    Yuan Y; Nie H
    Cell Oncol (Dordr); 2021 Feb; 44(1):33-44. PubMed ID: 33469838
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6).
    Yang H; Zhang Q; Zhou S; Hu Z; Tang Q; Li Z; Feng Q; Yu L
    Bioorg Chem; 2024 Jul; 148():107439. PubMed ID: 38754310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
    Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
    Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).
    Kaniskan HÜ; Szewczyk MM; Yu Z; Eram MS; Yang X; Schmidt K; Luo X; Dai M; He F; Zang I; Lin Y; Kennedy S; Li F; Dobrovetsky E; Dong A; Smil D; Min SJ; Landon M; Lin-Jones J; Huang XP; Roth BL; Schapira M; Atadja P; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Zhao K; Jin J; Vedadi M
    Angew Chem Int Ed Engl; 2015 Apr; 54(17):5166-70. PubMed ID: 25728001
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design, synthesis and anti leukemia cells proliferation activities of pyrimidylaminoquinoline derivatives as DOT1L inhibitors.
    Zhang L; Chen Y; Liu N; Li L; Xiao S; Li X; Chen K; Luo C; Chen S; Chen H
    Bioorg Chem; 2018 Oct; 80():649-654. PubMed ID: 30059890
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
    Wang M; Fuhrmann J; Thompson PR
    Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors.
    Asberry AM; Cai X; Deng X; Santiago U; Liu S; Sims HS; Liang W; Xu X; Wan J; Jiang W; Camacho CJ; Dai M; Hu CD
    J Med Chem; 2022 Oct; 65(20):13793-13812. PubMed ID: 36206451
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy.
    Tang Y; Huang S; Chen X; Huang J; Lin Q; Huang L; Wang S; Zhu Q; Xu Y; Zou Y
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies.
    Abumustafa W; Zamer BA; Khalil BA; Hamad M; Maghazachi AA; Muhammad JS
    Biomed Pharmacother; 2022 Jan; 145():112368. PubMed ID: 34794114
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
    Radzisheuskaya A; Shliaha PV; Grinev V; Lorenzini E; Kovalchuk S; Shlyueva D; Gorshkov V; Hendrickson RC; Jensen ON; Helin K
    Nat Struct Mol Biol; 2019 Nov; 26(11):999-1012. PubMed ID: 31611688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer.
    Chen Y; Zhang M; Wu A; Yao X; Wang Q
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.
    Chen Y; Wang Z; Zhang J; Shi Q; Yang H; Deng Y; Wang X; Liu T; Geng M; Xiong B; Huang X
    Eur J Med Chem; 2024 Mar; 267():116171. PubMed ID: 38301329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
    Li M; An W; Xu L; Lin Y; Su L; Liu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma.
    Gullà A; Hideshima T; Bianchi G; Fulciniti M; Kemal Samur M; Qi J; Tai YT; Harada T; Morelli E; Amodio N; Carrasco R; Tagliaferri P; Munshi NC; Tassone P; Anderson KC
    Leukemia; 2018 Apr; 32(4):996-1002. PubMed ID: 29158558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
    Hu H; Qian K; Ho MC; Zheng YG
    Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
    Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
    J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays.
    Ye F; Zhang W; Lu W; Xie Y; Jiang H; Jin J; Luo C
    Biomed Res Int; 2016; 2016():7086390. PubMed ID: 27872854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.